Dr. Jonathan Seth Weissman (born 1966)
Middle name "Seth" : https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143024036.14
Born 16 Apr 1966 ( https://www.ancestry.com/discoveryui-content/view/185938525:1732?tid=&pid=&queryId=41539adaa322d1181787da31da4caad3&_phsrc=llt24&_phstart=successSource )
Parents : Father is Dr. Sherman Morton Weissman (born 1930) , ....
Saved Wikipedia (April 19, 2021) - "Jonathan Weissman"
2021-04-19-wikipedia-org-jonathan-weissman.pdf
https://en.wikipedia.org/wiki/Jonathan_Weissman
Nationality
Alma mater
Harvard University, MIT, Yale University
Known for
Ribosome profiling Protein folding
Awards
Protein Society Irving Sigal Young Investigator Award (2004)
National Academy of Sciences Award for Scientific Discovery (2015)
Scientific career
Fields
Institutions
Other academic advisors
Jonathan S. Weissman is the Landon T. Clay Professor of Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute, and a Howard Hughes Medical Institute Investigator. From 1996 to 2020, he was a faculty member in the department of Cellular Molecular Pharmacology at the University of California, San Francisco.
He earned his B.A. in Physics from Harvard College (1988) and his Ph.D. in Physics (1993) from MIT working with Peter Kim. There, he started his studies on protein folding examining Bovine pancreatic trypsin inhibitor (BPTI).[1]
He was a postdoctoral fellow at Yale University (1993-1996), where he worked with Arthur Horwich studying the mechanism of GroEL.[2][3]
Weissman's research team studies how cells ensure that proteins fold into their correct shape, as well as the role of protein misfolding in disease and normal physiology. The team also develops experimental and analytical approaches for exploring the organizational principles of biological systems and globally monitoring protein translation through ribosome profiling. A broad goal of his work is to bridge large-scale approaches and in depth mechanistic investigations to reveal the information encoded within genomes.[4][5][6]
Weissman has been a member of the National Academy of Sciences since 2009.
^ Hoffman, M (Sep 20, 1991). "Straightening out the protein folding puzzle". Science. 253 (5026): 1357–8. Bibcode:1991Sci...253.1357H. doi:10.1126/science.1896845. PMID 1896845. S2CID 38632703.
^ Weissman, JS; Hohl, CM; Kovalenko, O; Kashi, Y; Chen, S; Braig, K; Saibil, HR; Fenton, WA; Horwich, AL (Nov 17, 1995). "Mechanism of GroEL action: productive release of polypeptide from a sequestered position under GroES". Cell. 83 (4): 577–87. doi:10.1016/0092-8674(95)90098-5. PMID 7585961. S2CID 17839893.
^ Weissman, Jonathan S.; O'Shea, Erin K. (1 January 2009). "2004 Irving Sigal Young Investigator Award". Protein Science. 13 (12): 3333–3335. doi:10.1110/ps.041134604. PMC 2287319. PMID 15557272.
^ "New Technique Focuses on Transcription". HHMI. 20 January 2011. Retrieved 14 February 2013.
^ Ingolia, Nicholas T.; Lareau, Liana F.; Weissman, Jonathan S. (1 November 2011). "Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes". Cell. 147 (4): 789–802. doi:10.1016/j.cell.2011.10.002. PMC 3225288. PMID 22056041.
^ "Jonathan S. Weissman". HHMI. Retrieved 14 February 2013.
1999 (Dec 17) - Published Research : Origin of the West Nile Virus Responsible for an Outbreak of Encephalitis in the Northeastern United States
https://pubmed.ncbi.nlm.nih.gov/10600742/
1999 Dec 17;286(5448):2333-7. doi: 10.1126/science.286.5448.2333.
PMID: 10600742 / DOI: 10.1126/science.286.5448.2333
https://science.sciencemag.org/content/286/5448/2333 / https://sci-hub.se/10.1126/science.286.5448.2333
1999-12-aaas-sciencemag-vol-286-origin-of-west-nile-responsible-for-outbreak.pdf
https://drive.google.com/file/d/1jmF68l_ymJuiz7VWHpnnrSGyjIw5Ctfh/view?usp=sharing
1999-12-aaas-sciencemag-vol-286-origin-of-west-nile-responsible-for-outbreak-pg-2336.jpg (-33 / -34 / --35)
https://drive.google.com/file/d/1bgX4s71BSEO09gDH6W3ugX9tmCs2r65K/view?usp=sharing
https://drive.google.com/file/d/1g_xQdB3oMmYvowwubWA8_fBZMJufUks1/view?usp=sharing
https://drive.google.com/file/d/1u-MclEJtjG_HLKltakXCSAHUQ_fujBFi/view?usp=sharing
https://drive.google.com/file/d/1nl6BGMq6igwP-n-CPmAxaQ26NfU2mnxy/view?usp=sharing
Authors :
[Dr. Robert Salvatore Lanciotti (born 1960)] - Zika virus mistakes / "whistleblower" ?
[Dr. John Timothy Roehrig (born 1952)] ( Work w/ Robert Shope ? ... )
V. Deubel,2
J. Smith,3
M. Parker,3
K. Steele
B. Crise
K. E. Volpe
M. B. Crabtree,
J. H. Scherret,4
R. A. Hall,4
C. B. Cropp,1
B. Panigrahy
E. Ostlund
B. Schmitt
M. Malkinson
C. Banet,
[Dr. Jonathan Seth Weissman (born 1966)] : [ father is Dr. Sherman Morton Weissman (born 1930) (mentored Dr. Francis Sellers Collins (born 1950)) ]
N. Komar,
H. M. Savage,
W. Stone,7
[Dr. Duane J. Gubler (born 1939)] : [ Dr. D.J. Gubler is a peer of Dr. Lin-Fa Wang (born 1960) ]
In late summer 1999, an outbreak of human encephalitis occurred in the north- eastern United States that was concurrent with extensive mortality in crows (Corvus species) as well as the deaths of several exotic birds at a zoological park in the same area. Complete genome sequencing of a flavivirus isolated from the brain of a dead Chilean flamingo (Phoenicopterus chilensis), together with partial sequence analysis of envelope glycoprotein (E-glycoprotein) genes amplified from several other species including mosquitoes and two fatal human cases, revealed that West Nile (WN) virus circulated in natural transmission cycles and was responsible for the human disease. Antigenic mapping with E-glycoprotein–specific monoclonal antibodies and E-glycoprotein phylogenetic analysis confirmed these viruses as WN. This North American WN virus was most closely related to a WN virus isolated from a dead goose in Israel in 1998.
In late August and early September 1999,
New York City and surrounding areas experienced
an outbreak of human encephalitis
consistent with an arboviral etiology. Serological
evidence from this outbreak implicated
a flavivirus as the etiologic agent. Concur-
rent with this human encephalitis outbreak, a
viral encephalitis of unknown etiology was
discovered in American crows (Corvus
brachyrhynchos) and fish crows (Corvus ossifragus)
dying in the same geographic area.
Deaths were also observed among several
exotic avian species, including a Chilean flamingo
(Phoenicopterus chilensis) at the
Bronx Zoo. Necropsy samples from these
birds were submitted to the National Veterinary
Services Laboratories, U.S. Department
of Agriculture, and were inoculated into embryonated
chicken eggs for virus isolation.
Flavivirus-like particles (diameter 40 nm)
were observed by electron microscopy in the
allantoic fluid 4 days after inoculation. The
isolates were forwarded to the Centers for
Disease Control and Prevention (CDC) for
identification.
The complete nucleotide sequence of one
of these viral isolates (WN-NY99, from the
dead Chilean flamingo) has now been determined.
The viral genomic RNA was amplified
and copied into overlapping DNA fragments
of ;2 to 3 kb by means of the reverse
transcription polymerase chain reaction (RTPCR)
(1). Both strands of the purified DNAs
were sequenced with the use of primers
spaced about 400 bases apart along the entire
genome. The complete 11,029-nucleotide
genomic sequence of WN-NY99 has been
submitted to GenBank (accession number
AF196835). The deduced amino acid sequence
of the coding region of WN-NY99
(genomic positions 97 to 10,395) is shown in
Fig. 1. The WN-NY99 virus genome exhibited
standard flavivirus genomic organization,
the same overall genomic organization
as was described for the WN-Nigeria and
Kunjin (KUN) viruses (2). A short 59 noncoding
region of 96 nucleotides is followed
by an ATG initiation codon at position 97 and
a single open reading frame of 10,302 nucleotides
coding for three structural proteins—
capsid, premembrane ( prM), and envelope
(E)—and five nonstructural proteins (NS1,
NS2a/NS2b, NS3, NS4a/NS4b, and NS5).
The coding region of WN-NY99 is followed
by a 39 noncoding region of 631 nucleotides.
To identify the New York virus antigenically,
we performed indirect immunofluorescence
antibody tests using a panel of welldefined
monoclonal antibodies (mAbs) to
map various isolates from birds and mosquitoes.
The mAb end-point titers with the North
American isolates were compared to titers
derived with other representatives of the Japanese
encephalitis (JE) virus serocomplex of
flaviviruses (Table 1). These mAbs, which
are specific for the E-glycoprotein, can distinguish
WN virus from KUN virus and can
also distinguish either of these viruses from
other members of the JE virus serocomplex.
Viruses were grown in Vero cells, spotted
onto 12-well slides, air-dried, and fixed with
acetone before staining. All viruses reacted
similarly with the broad flavivirus-reactive,
positive-control mAb 4G2 (3, 4). None of
these viruses reacted with the negative-control
antibody, which is specific for the E1
glycoprotein of eastern equine encephalitis
(EEE), an unrelated alphavirus (5). All WN
isolates, including those from North America,
reacted specifically with the WN virus–specific
mAb H5.46, but not with the KUN
virus–specific mAb 10A1 (four- to eightfold
titer differences) (6–8). Similarly, only KUN
virus reacted with mAb 10A1, but not with
mAb H5.46. No KUN or WN viruses reacted
with either the St. Louis encephalitis (SLE)
virus–specific mAb 6B5A-2 or the Murray
Valley encephalitis (MVE) virus–specific
mAb 4B6C-2 (9, 10). These results type the
North American isolates as WN virus and not
as KUN, SLE, or MVE viruses.
WN virus belongs to the family Flaviviridae,
genus Flavivirus, and is a member of the
JE virus serocomplex, which also includes
JE, SLE, MVE, and KUN viruses, among
others (11). Flaviviruses are plus-sense, single-
stranded RNA viruses with a genome of
;11,000 nucleotides (2). Recently published
sequence and phylogenetic data suggest that,
within this serocomplex, KUN viruses appear
to be a subtype of WN virus rather than a
separate viral species (12). Although flaviviruses
are closely related to each other antigenically
and cross-react in serological tests
with polyclonal antisera, most have a rather
distinctive geographic distribution. Those of
the JE serocomplex are maintained in a natural
transmission cycle involving mosquito
vectors and bird reservoir hosts. Humans and
horses are usually incidental hosts.
To determine more precisely the relationships
between the WN-NY99 virus and other
related virus strains, we performed a phylogenetic
analysis on an informative region of
the E-glycoprotein gene (genome positions
1402 to 1656) (12, 13). Aligned nucleic acid
sequence data from 33 WN viruses, seven
KUN viruses, and one JE virus were analyzed
with the use of algorithms for parsimony
(PAUP), distance (MEGA; Fig. 2), and maximum
likelihood (fastDNAml) (14–17). The
phylogenetic trees generated by these analyses
had the same overall topology as that
previously observed, insofar as all WN and
KUN viruses are separated into two major
lineages (12, 13). Viruses in lineage 1 are
primarily of West African, Middle Eastern,
Eastern European, and Australian origin. Lineage
2 consists exclusively of viruses from
the African continent that have apparently not
been involved in human or equine outbreaks,
but rather are maintained in enzootic cycles.
Within lineage 1, the KUN viruses and
the Indian WN viruses both appear as
monophyletic sister clades to the European
and African WN viruses. The WN-NY99
virus is found within lineage 1 and is most
closely related to WN viruses that have
recently been isolated from North Africa,
Romania, Kenya, Italy, and the Middle
East. Of particular note is the close relationship
between the WN-NY99 virus and a
WN virus isolated from the brain of a dead
goose in Israel in 1998. Phylogenetic analysis
of a portion of the gene encoding the
NS5 protein and of the 39 noncoding region
(830 bases) of 12 WN and KUN viruses
also generates trees with nearly identical
topology, with WN-NY99 demonstrating
the closest relationship with lineage 1 WN
viruses (18). Flavivirus sequences amplified
from brain specimens from fatal hu-
man cases occurring in the New York City
outbreak have been analyzed by comparing
genomic sequences from the nonstructural
protein genes to single strains of KUN
and WN viruses (19). Briese et al. concluded
that the agent responsible for the New
York City area outbreak was most closely
related to KUN virus, and accordingly
called the outbreak virus Kunjin/West Nile–
like. The phylogenetic tree in Fig. 2 compares
40 WN and KUN viruses and is more representative
of the phylogeny among WN viruses.
To investigate these relationships further,
we derived additional sequence data from the
structural gene region of the genome ( positions
549 to 1826 in the genes encoding the
prM and E proteins) from selected isolates
obtained during the 1999 epidemic and compared
them to other WN strains within lineage
1 for which sequence data from this
region were available. Table 2 displays the
percent identity among these viruses. The
high degree of sequence similarity (.99.8%)
among the various strains circulating
throughout New York City and surrounding
counties and states indicates that a single WN
strain was introduced and circulated during
the U.S. WN virus outbreak. The identical
genomic sequences identified from human
brain specimens also confirm the association
of this WN-NY99 virus with human disease.
The small number of nucleotide substitutions
observed among the strains analyzed is indicative
of viral microevolution occurring during
the outbreak.
A high degree of similarity between all of
the U.S. WN viruses and the WN virus isolated
in Israel in 1998 (.99.8%) was observed.
Within these 1278 nucleotides (genome positions
549 to 1826), only two nucleotide differences
occurred between WN-NY99 and WNIsrael
1998. Although this high degree of homology
was unexpected, it could not have resulted
from cross-contamination of U.S. viruses
with the Israeli virus; the sequencing of the
WN-Israel 1998 virus was performed independently
at the Pasteur Institute, whereas the isolation
and sequencing of New York isolates
was carried out independently at CDC. For
comparison, analysis of this same region of
WN-NY99 with another virus within the same
lineage (Romania 1996, mosquito isolate) revealed
37 nucleotide differences (96.9% identity).
The cumulative data support the hypothesis
that the epidemic and epizootic observed in
the late summer of 1999 in the northeastern
United States ( primarily New York, New Jersey,
and Connecticut) are attributable to a WN
virus that has been circulating in the Mediterranean
region since 1998. It is noteworthy that
the WN-Israel 1998 virus was associated with
increased pathogenicity for birds, a property
also observed in the U.S. outbreak and previously
observed only experimentally (20). The
absence of reported human cases during this
Israeli epizootic may be due to background
human immunity to the WN virus in Israel.
The northeastern U.S. outbreak is the first
documented incidence of the WN virus in the
Western Hemisphere. This virus has a widespread
distribution in Africa, West Asia, and
the Middle East, occasionally causing epidemics
in Europe that are thought to be initiated by
viruses introduced by migrant birds (21). The
current epidemic of WN virus in New York
City is unprecedented and underscores the ease
with which pathogens can move among the
population centers of the world. It is not yet
known how the virus was introduced, nor how
long it has been in the United States. The extent
of its geographic distribution remains a mystery,
as does the long-term impact it may have
on human and animal health. The WN virus
could have entered the Western Hemisphere
through a number of mechanisms, including
travel by infected humans, importation of illegal
birds or other domestic pets, or unintentional
introduction of virus-infected ticks or mosquitoes.
Additional surveillance as well as field
and laboratory studies are in progress to help
address these questions. Because it cannot be
predicted whether the WN virus will reappear
in the year 2000 transmission season, all components
of the public health system must be
prepared with rapid surveillance and clinical
detection systems in place.
2020-11-one-world-one-health-congress-6th-programme-at-a-glance.png
Lipkin -> Karesh / Daszak
https://www.publichealth.columbia.edu/sites/default/files/legacy/_twobytwo_v4i1.pdf
2015
Meeting in Brief COMMITTEE ON SCIENCE, TECHNOLOGY, AND LAW POLICY AND GLOBAL AFFAIRS December 1-3, 2015
https://www.nap.edu/download/21913#
2015-national-academies-of-sciences-meeting-brief-international-summit-on-human-gene-editing-a-global-discussion
Contributors
National Academies of Sciences, Engineering, and Medicine; Policy and Global Affairs; Committee on Science, Technology, and Law; Steven Olson, Editor
Description
New biochemical tools have made it possible to change the DNA sequences of living organisms with unprecedented ease and precision. These new tools have generated great excitement in the scientific and medical communities because of their potential to advance biological understanding, alter the genomes of microbes, plants, and animals, and treat human diseases. They also have raised profound questions about how people may choose to alter not only their own DNA but the genomes of future generations.
Topics
Suggested Citation
National Academies of Sciences, Engineering, and Medicine. 2015. International Summit on Human Gene Editing: A Global Discussion. Washington, DC: The National Academies Press. https://doi.org/10.17226/21913.